Loading clinical trials...
Loading clinical trials...
Study of the Hemodynamic and Clinical Maturation of the Native Arteriovenous Fistula for Hemodialysis
Study of the features of hemodynamic and clinical maturation of the native arteriovenous fistula for hemodialysis.
This is a prospective, single-center, observational study, investigating the clinical and hemodynamic features of maturation of hemodialysis native arteriovenous fistula (AVF). Hemodynamic features under investigation are the diameter of the feeding brachial artery, volume of flow (VF) measured with transcutaneous Duplex ultrasound (DUS), resistivity index (RI), diameter and wall thickness of the efferent vein, measured at days 1, 2, 3, 4, 5, 6, 7, 14, 21, 30, 60 and 90 post creation. Clinical features of maturation are the time of first access successful cannulation and the performance of three consecutive adequate dialysis sessions.
Age
18 - 95 years
Sex
ALL
Healthy Volunteers
No
Mediterranean Hospital
Glyfada, Attica, Greece
Start Date
February 1, 2019
Primary Completion Date
February 20, 2022
Completion Date
February 20, 2022
Last Updated
March 23, 2022
86
ACTUAL participants
Doppler ultrasound study
DIAGNOSTIC_TEST
Lead Sponsor
Medifil AE
Collaborators
NCT04634916
NCT06933472
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions